Legalise It Don't Criticize It Playlist

Post in evidenza

Marijuana and Vaping Are More Popular Than Cigarettes Among Teenagers

Vaping has increased among 12th-graders, with nearly 1 in 3 saying they used some kind of vaping device in the last year, according to ...


domenica 1 maggio 2016

Cannabis Genomes

Scientists map cannabis genomes to help protect the 
plant from big agricultural corporations,
like Monsanto, that might try to patent certain strains. 
The genome mapping effort led by 
Mowgli Holmes and the startup company 

Scientists at Phylos start by gathering samples from as much different cannabis strains 
as they can. They then analyze the genetic makeup of each one and figure out which 
strains a sample is most similar to.
All the information gets organized into what Phylos calls the “Galaxy.”
The Phylos Galaxy is a massive family tree of the cannabis plant that includes hundreds
of strains.
On the company’s website, the Galaxy is presented as a 3-D model that visitors can 
browse. Phylos launched the Galaxy on 4/20.
Strains that are genetically similar to one another are placed close to each other on the 
3-D map. Users can then move around on the map to see the genetic lineage of their 
favorite strains.
According to Phylos, the thing that makes the Galaxy different from other online catalogs
of cannabis strains is that each strain is individually sequenced.
But the genome mapping project isn’t just about trying to understand the full genetic makeup
of the cannabis plant. It’s also about protecting the plant as the marijuana industry moves
into the future.
According to the folks at Phylos, the Galaxy could protect cannabis strains from being 
patented by big agricultural companies like Monsanto.
For a company to get an agricultural patent, it must show that the genome of its plant
is significantly different from naturally occurring ones.
On top of that, companies can’t get a patent on anything in the public domain for longer 
than a year.
Phylos thinks that the more genetic information its scientists can process and make 
publicly available, the less room there will be for corporations to claim a patent on any 
individual strain.
“We think Big Pharma and Big Ag will be the primary audience after patents,” said 
 Phylos Sales and Marketing Manager Carolyn White.
“[But] you can’t patent anything that’s been in the public domain longer than a year.
We set out to bring more knowledge and transparency to the industry, and that’s still
what we’re doing.”
The effort is ongoing to have scientists map cannabis genomes. In the next few months, 
Phylos will begin a program that allows people to send in a plant sample. The sample will then
be analyzed and placed into its spot in the Galaxy.

Scientists Map Cannabis Genomes To Protect Pot From Monsanto APRIL 30, 2016 CHUCK LUDLEY

Nessun commento:

Posta un commento

Related Posts Plugin for WordPress, Blogger...